Rachel Sachs

Washington University in Saint Louis - School of Law

Associate Professor

Campus Box 1120

St. Louis, MO 63130

United States

  • Washington University in Saint Louis - School of Law

SCHOLARLY PAPERS

22

DOWNLOADS
Rank 16,913

SSRN RANKINGS

Top 16,913

in Total Papers Downloads

4,871

SSRN CITATIONS
Rank 41,799

SSRN RANKINGS

Top 41,799

in Total Papers Citations

10

CROSSREF CITATIONS

8

Scholarly Papers (22)

Actions:
Email selected abstracts
1.

New Innovation Models in Medical AI

99 Wash. U. L. Rev. 1121 (2022), U of Michigan Public Law Research Paper No. 21-009
Number of pages: 53 Posted: 20 Feb 2021 Last Revised: 06 Apr 2022
W. Nicholson Price II, Rachel Sachs and Rebecca S. Eisenberg
University of Michigan Law School, Washington University in Saint Louis - School of Law and University of Michigan Law School
Downloads 608 (71,828)
Citation 2

Abstract:

Loading...

artificial intelligence, user innovation, intellectual property, FDA law, medical AI

2.

Innovative Contracting for Pharmaceuticals and Medicaid's Best-Price Rule

Journal of Health Politics, Policy and Law, Forthcoming, U of Michigan Public Law Research Paper No. 549
Number of pages: 14 Posted: 29 Apr 2017 Last Revised: 13 May 2017
Rachel Sachs, Nicholas Bagley and Darius N. Lakdawalla
Washington University in Saint Louis - School of Law, University of Michigan Law School and University of Southern California - Schaeffer Center for Health Policy and Economics
Downloads 486 (94,729)
Citation 1

Abstract:

Loading...

drugs, drug prices, Medicaid, value-based purchasing

3.

Innovation Law and Policy: Preserving the Future of Personalized Medicine

49 U.C. Davis L. Rev., 2016 Forthcoming
Number of pages: 52 Posted: 22 Apr 2015 Last Revised: 21 Jan 2016
Rachel Sachs
Washington University in Saint Louis - School of Law
Downloads 399 (119,431)

Abstract:

Loading...

4.

Delinking Reimbursement

Minnesota Law Review, Forthcoming, Washington University in St. Louis Legal Studies Research Paper
Number of pages: 46 Posted: 14 Feb 2018
Rachel Sachs
Washington University in Saint Louis - School of Law
Downloads 326 (149,234)

Abstract:

Loading...

FDA, CMS, Reimbursement, Access, Innovation

5.

The Medicare Innovation Subsidy

New York University Law Review, Vol. 95, p. 75, 2020, Stanford Law and Economics Olin Working Paper No. 536
Number of pages: 55 Posted: 24 Aug 2019 Last Revised: 22 May 2020
Mark A. Lemley, Lisa Larrimore Ouellette and Rachel Sachs
Stanford Law School, Stanford Law School and Washington University in Saint Louis - School of Law
Downloads 323 (150,709)
Citation 1

Abstract:

Loading...

innovation policy, intellectual property, insurance, health care, Medicare, Medicaid, prescription drugs

6.

Prizing Insurance: Prescription Drug Insurance as Innovation Incentive

Harvard Journal of Law and Technology, Vol. 30, No. 1, Forthcoming
Number of pages: 56 Posted: 20 Apr 2016
Rachel Sachs
Washington University in Saint Louis - School of Law
Downloads 321 (151,731)
Citation 3

Abstract:

Loading...

Patent Law, Health Law, Insurance, Prizes

7.

Ensuring the Safe and Effective FDA Regulation of Fecal Microbiota Transplantation

Journal of Law and the Biosciences, Vol. 2, p. 396, 2015
Number of pages: 19 Posted: 27 May 2015 Last Revised: 21 Jan 2016
Rachel Sachs and Carolyn Edelstein
Washington University in Saint Louis - School of Law and OpenBiome
Downloads 290 (168,818)
Citation 3

Abstract:

Loading...

8.

Cryptic Patent Reform Through the Inflation Reduction Act

Harvard Journal of Law & Technology, Forthcoming, Duke Law School Public Law & Legal Theory Series No. 2023-25, U of Michigan Law & Econ Research Paper No. 23-021, U of Michigan Public Law Research Paper No. 23-021
Number of pages: 46 Posted: 11 Apr 2023 Last Revised: 11 May 2023
Arti K. Rai, Rachel Sachs and W. Nicholson Price II
Duke University School of Law, Washington University in Saint Louis - School of Law and University of Michigan Law School
Downloads 191 (252,468)

Abstract:

Loading...

patents, drug pricing

9.

Innovation Law and COVID-19: Promoting Incentives and Access for New Healthcare Technologies

Forthcoming in I. Glenn Cohen, Abbe Gluck, Katherine Kraschel, & Carmel Shachar, COVID-19 and the Law: Disruption, Impact and Legacy. Cambridge University Press, 2022, University of Illinois College of Law Legal Studies Research Paper No. 21-14
Number of pages: 12 Posted: 07 Jun 2021
Rachel Sachs, Lisa Larrimore Ouellette, W. Nicholson Price II and Jacob S. Sherkow
Washington University in Saint Louis - School of Law, Stanford Law School, University of Michigan Law School and University of Illinois College of Law
Downloads 180 (266,227)

Abstract:

Loading...

COVID-19, innovation policy, vaccines, FDA

10.

Innovation Institutions and COVID-19

University of Illinois College of Law Legal Studies Research Paper No. 21-09
Number of pages: 157 Posted: 15 Apr 2021
Lisa Larrimore Ouellette, W. Nicholson Price II, Rachel Sachs and Jacob S. Sherkow
Stanford Law School, University of Michigan Law School, Washington University in Saint Louis - School of Law and University of Illinois College of Law
Downloads 180 (266,227)

Abstract:

Loading...

COVID-19, innovation policy, public health, intellectual property law, R&D, grants, procurement, NIH, FDA, EUA, CMS, vaccines, diagnostics, antibody testing, remdesivir, therapeutic antibodies, convalescent serum therapy, pharmaceutical manufacturing, clinical trials, N95s, 3D printing, AI

11.

Integrating Health Innovation Policy

Harvard J. L. & Tech. (2020 Forthcoming), Washington University in St. Louis Legal Studies Research Paper No. 20-10-01
Number of pages: 60 Posted: 23 Apr 2020 Last Revised: 20 Oct 2020
Rachel Sachs
Washington University in Saint Louis - School of Law
Downloads 176 (271,438)

Abstract:

Loading...

Health Law, Food and Drug Regulation, Intellectual Property Law

12.

The Role of State Attorneys General in Improving Prescription Drug Affordability

Southern California Law Review, Forthcoming
Number of pages: 94 Posted: 12 Oct 2021
Michelle M. Mello, Trish Riley and Rachel Sachs
Stanford Law School, affiliation not provided to SSRN and Washington University in Saint Louis - School of Law
Downloads 171 (278,410)

Abstract:

Loading...

Drug pricing, health law, state attorneys general

13.

Divided Infringement and the Doctor-Patient Relationship

IP Theory (Forthcoming)
Number of pages: 12 Posted: 09 May 2016
Rachel Sachs
Washington University in Saint Louis - School of Law
Downloads 166 (285,460)

Abstract:

Loading...

Patent Law, Bioethics

14.

Administering Health Innovation

Cardozo Law Review (2018, Forthcoming)
Number of pages: 54 Posted: 07 Aug 2017
Rachel Sachs
Washington University in Saint Louis - School of Law
Downloads 159 (296,054)

Abstract:

Loading...

NIH, FDA, CMS, Innovation Policy, Interagency Collaboration

15.

Encouraging Interagency Collaboration: Learning from COVID-19

Journal of Law & Innovation (2021 Forthcoming), Washington University in St. Louis Legal Studies Research Paper No. 21-05-03
Number of pages: 32 Posted: 01 Jun 2021
Rachel Sachs
Washington University in Saint Louis - School of Law
Downloads 154 (303,950)

Abstract:

Loading...

Innovation policy, health law, food & drug law

16.

The Accidental Innovation Policymakers

Duke Law Journal, Forthcoming
Number of pages: 52 Posted: 28 Apr 2022
Rachel Sachs
Washington University in Saint Louis - School of Law
Downloads 148 (314,131)
Citation 1

Abstract:

Loading...

Health Law, food and drug law, patent law, innovation policy

17.

Diagnostic Method Patents and Harms to Follow-On Innovation

Harvard Law Review, Vol. 126, No. 5, p. 1370, 2013
Number of pages: 22 Posted: 10 Oct 2014
Rachel Sachs
Washington University in Saint Louis - School of Law
Downloads 141 (326,471)

Abstract:

Loading...

18.

Rethinking Innovation at FDA

Boston University Law Review, Forthcoming, U of Michigan Public Law Research Paper No. 23-020
Number of pages: 70 Posted: 14 Mar 2023 Last Revised: 11 May 2023
Rachel Sachs, W. Nicholson Price II and Patricia J. Zettler
Washington University in Saint Louis - School of Law, University of Michigan Law School and Ohio State University (OSU) - Michael E. Moritz College of Law
Downloads 118 (373,424)

Abstract:

Loading...

Innovation, FDA, pharmaceutical policy

19.

Whether and How the U.S. Government Should Exercise Its Compulsory Licensing Authority Under 28 U.S.C. § 1498 and the Bayh-Dole Act

NYU Journal of Intellectual Property & Entertainment Law, 11, U of Michigan Public Law Research Paper 21-036, Duke Law School Public Law & Legal Theory Series No. 2022-07
Number of pages: 25 Posted: 18 Nov 2021 Last Revised: 09 Feb 2022
Arti K. Rai, Rebecca S. Eisenberg, Tahir Amin, Henry Hadad and Rachel Sachs
Duke University School of Law, University of Michigan Law School, Initiative for Medicines, Access & Knowledge (I-MAK), affiliation not provided to SSRN and Washington University in Saint Louis - School of Law
Downloads 99 (422,745)

Abstract:

Loading...

Symposium, Access, Medicine, COVID, Coronavirus, NYU, Prescription, Drugs, Government, Healthcare, Insurance, Research, Pharmaceutical, Pharma, NIH, Pandemic, Vaccine, Patent, Intellectual Property, IP, Licensing, 28 U.S.C. § 1498, Bayh-Dole Act, Public Health, Biomedical, Bioethics, Policy

20.

Making Intellectual Property Work for Global Health

Harvard International Law Journal Online, Vol. 53, p. 106, 2012
Number of pages: 38 Posted: 10 Oct 2014
Rachel Sachs
Washington University in Saint Louis - School of Law
Downloads 91 (446,275)

Abstract:

Loading...

21.

The New Model of Interest Group Representation in Patent Law

Yale Journal of Law & Technology, Vol. 16, p. 344, 2014
Number of pages: 53 Posted: 10 Oct 2014
Rachel Sachs
Washington University in Saint Louis - School of Law
Downloads 81 (479,144)

Abstract:

Loading...

22.

Innovation Institutions and COVID-19, Part II

Number of pages: 53 Posted: 08 Jul 2022
Lisa Larrimore Ouellette, W. Nicholson Price II, Rachel Sachs and Jacob S. Sherkow
Stanford Law School, University of Michigan Law School, Washington University in Saint Louis - School of Law and University of Illinois College of Law
Downloads 63 (549,589)

Abstract:

Loading...

COVID-19, innovation policy, public health, intellectual property law, R&D, grants, procurement, NIH, FDA, EUA, CMS, CDC, vaccines, diagnostics, antivirals, pharmaceuticals, clinical trials, pregnancy, long COVID, WTO, TRIPS, emergency declarations